Regul@Oli Pharma Consulting
The computed 12-month bankruptcy probability of Regul@Oli Pharma Consulting is 0.2% (very low). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 4 yrs |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| NACE primary | Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200) |
| Legal form | Limited partnership(612) |
| Incorporation | 27-04-2022 |
| Status | Active |
| Postal code | 1370 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25048F0443/00M000 | Wallonia | 8,565 m² | 1 · 57 m² | 8.5 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
08-06-2026 General meeting · Dissolution · Liquidation · Dissolution balance sheet
- Filing: 2026-05-26 · Regul@Oli Pharma Consulting
- General meeting: 2026-05-22 · Regul@Oli Pharma Consulting
- Dissolution: 2026-05-22 · Regul@Oli Pharma Consulting
- Liquidation: 2026-05-22 · Regul@Oli Pharma Consulting
- Dissolution balance sheet: date: 2026-04-30 · Regul@Oli Pharma Consulting
- Share distribution: amount: 303942.29, currency: EUR · Regul@Oli Pharma Consulting
- Officer discharge: period_end: 2026-05-22, period_start: 2026-01-01 · Olivier LECHIEN
- Power of attorney: purpose: accomplir les dernières formalités post-liquidation et notamment pour établir les déclarations à l'impôt des sociétés, radier l'inscription de la société auprès d'un guichet d'entreprises de la Banque Carrefour des entreprises et procéder aux formalités de publication aux Annexes du Moniteur Belge des résolutions prises dans ce procès-verbal · Regul@Oli Pharma Consulting
- Publication: 2026-06-08
- Act object: Dissolution en un acte - clôture de la société
Technical details
{
"facts": [
{
"type": "filing",
"quote": "2 6 MAI 2026",
"value": "2026-05-26",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire du 22/05/2026",
"value": "2026-05-22",
"object": null,
"subject": "e1"
},
{
"type": "dissolution",
"quote": "L\u0027Assembl\u00E9e d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de dissoudre et de liquider la soci\u00E9t\u00E9 en un seul acte.",
"value": "2026-05-22",
"object": null,
"subject": "e1"
},
{
"type": "liquidation",
"quote": "L\u0027Assembl\u00E9e d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de dissoudre et de liquider la soci\u00E9t\u00E9 en un seul acte.",
"value": "2026-05-22",
"object": null,
"subject": "e1"
},
{
"type": "dissolution_balance_sheet",
"quote": "L\u0027Assembl\u00E9e proc\u00E8de \u00E0 l\u0027examen du rapport sur les \u00E9tats financiers au 30 avril 2026. L\u0027\u00E9tat comptable tient compte des perspectives de liquidation de la soci\u00E9t\u00E9 et fait appara\u00EEtre un total de bilan de 303.942,29 \u20AC et un actif net de 303.942,29 \u20AC.",
"value": {
"date": "2026-04-30",
"net_assets": {
"amount": 303942.29,
"currency": "EUR"
},
"total_balance_sheet": {
"amount": 303942.29,
"currency": "EUR"
}
},
"object": null,
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "L\u0027actif net s\u0027\u00E9l\u00E8ve \u00E0 un montant de 303.942,29 \u20AC \u00E0 r\u00E9partir entre les Associ\u00E9s proportionnellement \u00E0 leur participation dans le capital social.",
"value": {
"amount": 303942.29,
"currency": "EUR",
"recipients": [
{
"shares": 95,
"entity_id": "Olivier LECHIEN"
},
{
"shares": 5,
"entity_id": "Gr\u00E9goire LECHIEN"
}
]
},
"object": null,
"subject": "e1"
},
{
"type": "officer_discharge",
"quote": "L\u0027assembl\u00E9e se prononce sur la d\u00E9charge \u00E0 donner \u00E0 l\u0027administrateur pour la mani\u00E8re dont il a rempli son mandat pendant l\u0027exercice comptable du 01/01/2026 jusqu\u0027\u00E0 ce jour. A l\u0027unanimit\u00E9, la d\u00E9charge est accord\u00E9e \u00E0 l\u0027administrateur.",
"value": {
"period_end": "2026-05-22",
"period_start": "2026-01-01"
},
"object": "e1",
"subject": "e2"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e d\u00E9cide de conf\u00E9rer tous pouvoirs \u00E0 Monsieur Olivier Lechien, administrateur-g\u00E9rant, afin d\u0027accomplir les derni\u00E8res formalit\u00E9s post-liquidation et notamment pour \u00E9tablir les d\u00E9clarations \u00E0 l\u0027imp\u00F4t des soci\u00E9t\u00E9s, radier l\u0027inscription de la soci\u00E9t\u00E9 aupr\u00E8s d\u0027un guichet d\u0027entreprises de la Banque Carrefour des entreprises et proc\u00E9der aux formalit\u00E9s de publication aux Annexes du Moniteur Belge des r\u00E9solutions prises dans ce proc\u00E8s-verbal.",
"value": {
"purpose": "accomplir les derni\u00E8res formalit\u00E9s post-liquidation et notamment pour \u00E9tablir les d\u00E9clarations \u00E0 l\u0027imp\u00F4t des soci\u00E9t\u00E9s, radier l\u0027inscription de la soci\u00E9t\u00E9 aupr\u00E8s d\u0027un guichet d\u0027entreprises de la Banque Carrefour des entreprises et proc\u00E9der aux formalit\u00E9s de publication aux Annexes du Moniteur Belge des r\u00E9solutions prises dans ce proc\u00E8s-verbal"
},
"object": "e2",
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 08/06/2026",
"value": "2026-06-08",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Dissolution en un acte - cl\u00F4ture de la soci\u00E9t\u00E9",
"value": "Dissolution en un acte - cl\u00F4ture de la soci\u00E9t\u00E9",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 5735,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0785.469.871",
"kind": "company",
"name": "Regul@Oli Pharma Consulting",
"attrs": {
"seat": "Hameau de Hussompont 10 \u00E0 1370 Jodoigne",
"legal_form": "Soci\u00E9t\u00E9 en commandite"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Olivier LECHIEN",
"attrs": {
"role": "associ\u00E9-commandit\u00E9, administrateur-g\u00E9rant"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Gr\u00E9goire LECHIEN",
"attrs": {
"role": "associ\u00E9-commanditaire"
}
}
]
}29-04-2022 Incorporation of a new SNC
Technical details
{
"kind": "oprichting",
"seat": "1370 Jodoigne, Hameau de Hussompont 10",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1966-06-09",
"name": "Olivier LECHIEN",
"niss": null,
"address": "1370 Jodoigne, Hameau de Hussompont 10"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1900,
"holder_person_name": "Olivier LECHIEN",
"is_subscriber_only": false,
"n_shares_subscribed": 95,
"amount_subscribed_eur": 1900,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "2000-10-23",
"name": "Gr\u00E9goire LECHIEN",
"niss": null,
"address": "1370 Jodoigne, Hameau de Hussompont 10"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 100,
"holder_person_name": "Gr\u00E9goire LECHIEN",
"is_subscriber_only": false,
"n_shares_subscribed": 5,
"amount_subscribed_eur": 100,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2000,
"subject_company": {
"kbo": "0785.469.871",
"name_full": "Regul@Oli Pharma Consulting",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2022-04-27",
"post_incorporation_mandates": []
}| Legal nameFR | Regul@Oli Pharma Consulting |